• LAST PRICE
    1.4400
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.6993%)
  • Bid / Lots
    1.4400/ 1
  • Ask / Lots
    1.4500/ 116
  • Open / Previous Close
    1.4500 / 1.4300
  • Day Range
    Low 1.4012
    High 1.4500
  • 52 Week Range
    Low 1.0500
    High 3.9700
  • Volume
    47,779
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 1.43
TimeVolumeICAD
09:32 ET2751.45
09:36 ET1001.44
09:38 ET8231.4456
09:45 ET10001.4499
10:08 ET1501.4012
10:10 ET7031.44
10:48 ET4761.4399
11:04 ET20001.4389
11:06 ET50001.4398
11:15 ET30001.4399
11:18 ET10001.4399
11:24 ET1001.4399
11:36 ET8101.44
12:02 ET19881.43
12:23 ET49741.41
12:27 ET20001.425
12:39 ET5101.4358
12:56 ET26001.42
01:28 ET99801.41
01:30 ET12001.4187
01:32 ET4511.43
01:37 ET1001.415
01:42 ET1001.4297
01:46 ET50001.42
01:57 ET3001.4296
02:24 ET5001.42
02:26 ET2001.4499
02:29 ET8271.44
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesICAD
ICAD Inc
38.0M
-5.3x
---
United StatesMDAI
Spectral AI Inc
31.3M
-1.1x
---
United StatesEKSO
Ekso Bionics Holdings Inc
22.4M
-1.1x
---
United StatesMICRD
Micron Solutions Inc
2.0M
-0.7x
---
United StatesPRPO
Precipio Inc
8.4M
-1.2x
---
United StatesINND
InnerScope Hearing Technologies, Inc.
2.7M
0.0x
---
As of 2024-05-01

Company Information

iCAD, Inc. is a global medical technology company, which provides cancer detection and therapy solutions. The Company is focused on providing breast cancer detection solutions built on artificial intelligence (AI) that empowers radiologists to find cancers. Its solutions include advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the most prevalent cancers earlier, and a range of high-performance, AI and computer-aided detection (CAD) systems and workflow solutions for 2D and 3D mammography, magnetic resonance imaging and computed tomography (CT). The Company’s Breast AI Suite offers a triple threat of clinically proven cancer detection, density assessment, and risk evaluation solutions, designed to accelerate discovery and improve outcomes. It also offers ProFound AI, a digital breast tomosynthesis (DBT) cancer detection and workflow solution.

Contact Information

Headquarters
98 Spit Brook Rd Ste 100NASHUA, NH, United States 03062-5737
Phone
603-882-5200
Fax
603-880-3843

Executives

Executive Chairman of the Board, President, Chief Executive Officer
Dana Brown
Chief Financial Officer
Eric Lonnqvist
Chief Operating Officer
Michelle Strong
Chief Technology Officer
Jonathan Go
Chief Product Officer
Vasu Avadhanula

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$38.0M
Revenue (TTM)
$17.3M
Shares Outstanding
26.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.36
EPS
$-0.27
Book Value
$1.27
P/E Ratio
-5.3x
Price/Sales (TTM)
2.2
Price/Cash Flow (TTM)
---
Operating Margin
-44.40%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.